MiR-7-5p was found to be upregulated in cisplatin-resistant cervical tumor cells, boosting energy production via targeting Bcl-2 and decreasing energy consumption through PARP-1 targeting. This evidence concerns the gene BCL2 and uterine cervix neoplasm.